, Tracking Stock Market Picks
Enter Symbol:
Omeros Corporation (OMER) [hlAlert]

up 51.24 %

Omeros Corporation (OMER) rated Buy with price target $13 by Canaccord Genuity

Posted on: Wednesday,  Mar 14, 2012  8:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Omeros Corporation (NASDAQ: OMER) on 03/14/2012, when the stock price was $10.42. Since
then, Omeros Corporation has gained 51.25% as of 01/26/2016's recent price of $15.76.
If you would have followed this Canaccord Genuity's recommendation on OMER, you would have gained 51.24% of your investment in 1413 days.

Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company?s clinically advanced product candidates are derived from its PharmacoSurgerytm platform designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/14/2012 8:25 AM Buy
10.42 13.00
as of 12/31/2012
1 Week down  -14.63 %
1 Month down  -30.61 %
3 Months down  -44.78 %
1 YTD down  -50.19 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy